Xenon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $26.74-$46 |
Market Cap | $2.8B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $7.5M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$245.1M |
Diluted EPS | -$3.55 |
News
See moreYahoo Finance • 18 hours ago
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
Yahoo Finance • 16 days ago
Design Therapeutics Appoints Justin Gover to Board of Directors
Yahoo Finance • 28 days ago
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
CFO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
Address | 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 316 |
